Caredx unveils new patient-centered medication management features on allocare mobile health app

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) – the transplant company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that its allocare® mobile health app features expanded medication adherence and patient-provider communication capabilities resulting from the successful integration of medactionplan®, an acquisition made last year. medactionplan
CDNA Ratings Summary
CDNA Quant Ranking